Abstract | OBJECTIVES: METHODS: We developed a rat model of T/HS followed by Pseudomonas aeruginosa (PA) pneumonia to assess the effect of alveolar epithelial cell (AEC) apoptosis, and its prevention by IL-6, on lung surfactant protein ( SP)-D protein levels, lung bacterial burden, and survival from PA pneumonia, as well as to determine whether AEC apoptosis is a consequence of the unfolded protein response (UPR). Lung UPR transcriptome analysis was performed on rats subjected to sham, T/HS, and T/HS plus IL-6 protocols. Group comparisons were performed via Kaplan-Meier or ANOVA. RESULTS: T/HS decreased lung SP-D by 1.8-fold (p < 0.05), increased PA bacterial burden 9-fold (p < 0.05), and increased PA pneumonia mortality by 80% (p < 0.001). IL-6, when provided at resuscitation, normalized SP-D levels (p < 0.05), decreased PA bacterial burden by 4.8-fold (p < 0.05), and prevented all mortality from PA pneumonia (p < 0.001). The UPR transcriptome was significantly impacted by T/HS; IL-6 treatment normalized the T/HS-induced UPR transcriptome changes (p < 0.05). CONCLUSIONS: Impaired innate lung defense occurs following T/HS and is mediated, in part, by reduction in SP-D protein levels, which, along with AEC apoptosis, may be mediated by the UPR, and prevented by use of IL-6 as a resuscitation adjuvant.
|
Authors | Stephen Thacker, Ana Moran, Mihalis Lionakis, Mary-Ann A Mastrangelo, Tripti Halder, Maria del Pilar Huby, Yong Wu, David J Tweardy |
Journal | The Journal of infection
(J Infect)
Vol. 68
Issue 3
Pg. 231-41
(Mar 2014)
ISSN: 1532-2742 [Electronic] England |
PMID | 24291043
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | Copyright © 2013 The British Infection Association. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
- Interleukin-6
- Pulmonary Surfactant-Associated Protein D
|
Topics |
- Analysis of Variance
- Animals
- Apoptosis
(physiology)
- Disease Models, Animal
- Interleukin-6
(administration & dosage, pharmacology)
- Pneumonia
(prevention & control)
- Pulmonary Surfactant-Associated Protein D
(metabolism)
- Rats
- Shock, Hemorrhagic
(physiopathology)
- Unfolded Protein Response
(drug effects, physiology)
|